PNC Financial Services Group Inc. Sells 2,023 Shares of Sanofi (NASDAQ:SNY)

PNC Financial Services Group Inc. reduced its holdings in Sanofi (NASDAQ:SNY) by 1.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 103,701 shares of the company’s stock after selling 2,023 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Sanofi were worth $5,976,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Stablepoint Partners LLC grew its position in shares of Sanofi by 0.8% during the 3rd quarter. Stablepoint Partners LLC now owns 23,893 shares of the company’s stock worth $1,377,000 after buying an additional 189 shares during the period. PDS Planning Inc increased its stake in Sanofi by 3.1% in the third quarter. PDS Planning Inc now owns 6,643 shares of the company’s stock valued at $383,000 after purchasing an additional 200 shares in the last quarter. Eagle Ridge Investment Management raised its holdings in shares of Sanofi by 3.8% during the third quarter. Eagle Ridge Investment Management now owns 5,571 shares of the company’s stock valued at $321,000 after purchasing an additional 203 shares during the period. Financial Advocates Investment Management boosted its position in shares of Sanofi by 3.4% during the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock worth $365,000 after purchasing an additional 206 shares in the last quarter. Finally, Angeles Investment Advisors LLC grew its stake in shares of Sanofi by 1.9% in the 3rd quarter. Angeles Investment Advisors LLC now owns 11,323 shares of the company’s stock valued at $653,000 after buying an additional 210 shares during the period. 10.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Stock Up 0.6 %

SNY stock opened at $48.28 on Friday. The stock’s 50 day moving average is $53.70 and its 200-day moving average is $52.17. Sanofi has a twelve month low of $45.22 and a twelve month high of $58.97. The firm has a market capitalization of $122.53 billion, a PE ratio of 24.63, a P/E/G ratio of 1.22 and a beta of 0.61. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Friday, October 25th. The company reported $1.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. The firm had revenue of $13.44 billion for the quarter, compared to the consensus estimate of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The business’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.55 EPS. Sell-side analysts expect that Sanofi will post 4.29 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on SNY. Citigroup upgraded Sanofi to a “strong-buy” rating in a report on Tuesday, September 17th. StockNews.com downgraded shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 7th. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.